For Prelims: Narcotics Control Bureau (NCB), Drug Policy Framework, Precursor Control, Full form of NCB, Full form of ONDCP, Meeting, Date, Venue
For Mains: Transnational crime, bilateral cooperation, precursor diversion, supply chain integrity, demand reduction
Source:
The Hindu
5 facts for one-day exams
SSC, railway, police and teaching exams ask direct questions like these.
- The 2nd India-U.S. Drug Policy Executive Working Group Meeting was held on November 2-3, 2026.
- The meeting was hosted by the Narcotics Control Bureau (NCB) in New Delhi.
- The Indian delegation was led by NCB Director General Anurag.
- The U.S. delegation was led by Debbie Seguin, Acting Deputy Director, ONDCP.
- The meeting reviewed bilateral cooperation on intelligence sharing, precursor control, and supply chain integrity.
Why in the news?
India and the U.S. agreed to coordinated action against emerging narcotic threats at the 2nd India-U.S. Drug Policy Executive Working Group Meeting (Nov 2-3, 2026, New Delhi). The meeting reviewed bilateral cooperation on intelligence sharing, law enforcement, precursor control, and supply chain integrity under the India-U.S. Drug Policy Framework.
Summary
- The 2nd India-United States Drug Policy Executive Working Group Meeting was hosted by the Narcotics Control Bureau (NCB) on November 2-3, 2026, in New Delhi.
- Both sides agreed to strengthen intelligence sharing, coordinated law enforcement, precursor control, pharmaceutical supply chain integrity, and drug demand reduction.
- India's Vision Roadmap 2026-2029 against drug trafficking was highlighted by NCB Director General Anurag.
Highlights
Bilateral Cooperation
India and the U.S. agreed to coordinated action against emerging drug threats at the 2nd Executive Working Group Meeting.
Priority Areas
Intelligence sharing, coordinated law enforcement, precursor control, pharmaceutical supply chain integrity, and demand reduction.
Vision Roadmap 2026-2029
India's anti-drug strategy, formulated under PM Modi and Home Minister Amit Shah, was highlighted by NCB.
Key Analysis and Impact
The meeting focused on synthetic drugs and precursor chemical diversion, which are major threats globally. Strengthening intelligence sharing and coordinated law enforcement directly targets drug cartels. The emphasis on pharmaceutical supply chain integrity addresses the diversion of licit drugs to illicit markets. India's Vision Roadmap 2026-2029 signals a proactive domestic and international stance.
Way Forward
Sustained institutional engagement and timely intelligence exchange are critical. Both sides will continue sharing best practices in targeted law enforcement. The cooperation is expected to lead to operational results, including disruption of trafficking networks and securing commercial supply chains.
Background GK
Textbook concepts you need to understand this news
- Narcotics Control Bureau (NCB)
- India's federal anti-narcotics agency under the Ministry of Home Affairs, responsible for coordinating drug law enforcement and implementing the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985.
- Drug Policy Framework
- A bilateral agreement between two countries outlining the terms of cooperation, intelligence sharing, and joint action against drug trafficking and abuse.
- Precursor Control
- Regulation of chemicals used in the manufacture of illicit drugs, preventing their diversion from legitimate industrial or pharmaceutical use.
Facts to remember
Tap a card to see the answer. Try to recall it first.
How exams will ask this
- Data: 2nd India-U.S. Drug Policy Executive Working Group Meeting, November 2-3, 2026, New Delhi
- Nodal Body: Narcotics Control Bureau (NCB), Ministry of Home Affairs
- Legal Point: Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985
Don't make this mistake!
Examiners may swap 'Executive Working Group' with 'Joint Working Group' or confuse NCB with the Central Bureau of Investigation (CBI). The NCB is specifically the anti-narcotics agency under the MHA.
Write these in mains answers
- Transnational crime, bilateral cooperation, precursor diversion, supply chain integrity, demand reduction
Stuck? Get it in one tap
India and the United States held a meeting in New Delhi to strengthen their joint fight against illegal drugs. They agreed to share more intelligence, coordinate police actions, and control chemicals used to make drugs. India also presented its anti-drug plan for 2026-2029.
- The 2nd India-U.S. Drug Policy Executive Working Group Meeting was held on November 2-3, 2026.
- The meeting was hosted by the Narcotics Control Bureau (NCB) in New Delhi.
- The Indian delegation was led by NCB Director General Anurag.
- The U.S. delegation was led by Debbie Seguin, Acting Deputy Director, ONDCP.
- The meeting reviewed bilateral cooperation on intelligence sharing, precursor control, and supply chain integrity.
- International Relations: Bilateral agreements and cooperation with the U.S.
- Security: Transnational crime and drug trafficking
Related concepts: Narcotics Control Bureau (NCB), Drug Policy Framework, Precursor Control
Practice questions
Pick an answer, then read the explanation.
- Q1Easy
Which Indian agency hosted the 2nd India-U.S. Drug Policy Executive Working Group Meeting?
Explanation: The Narcotics Control Bureau (NCB) is India's federal anti-narcotics agency under the Ministry of Home Affairs. It hosted the 2nd India-U.S. Drug Policy Executive Working Group Meeting. The CBI handles general crime and corruption, IB handles intelligence, and ED handles economic offences.
- Q2Hard
Consider the following statements:
- 1.The 2nd India-U.S. Drug Policy Executive Working Group Meeting was held in New Delhi.
- 2.The U.S. delegation was led by the Director of the Federal Bureau of Investigation.
- 3.The meeting reviewed bilateral cooperation in combatting illicit drug trafficking.
Which of the statements given above is/are correct?
Explanation: Statement 1 is correct because the meeting was held in New Delhi on November 2-3, 2026. Statement 2 is incorrect as the U.S. delegation was led by Debbie Seguin, Acting Deputy Director of the Office of National Drug Control Policy (ONDCP), not the FBI Director. Statement 3 is correct as the meeting reviewed bilateral cooperation against illicit drug trafficking.
- Q3Medium
When was the 2nd India-U.S. Drug Policy Executive Working Group Meeting held?
Explanation: The NCB hosted the 2nd India-U.S. Drug Policy Executive Working Group Meeting on November 2-3, 2026. October 2-3 is incorrect, December 2-3 is incorrect, and November 10-11 is the date the news was published, not the meeting date.
- Q4Medium
What is the primary objective of the India-U.S. Drug Policy Framework?
Explanation: The India-U.S. Drug Policy Framework is designed to enhance cooperation against illicit drug trafficking through intelligence sharing, coordinated law enforcement, precursor control, and supply chain integrity. While pharmaceutical trade may be related, the core objective is combatting illicit trafficking, not pricing or military action.
Frequently asked questions
1. What is the India-U.S. Drug Policy Executive Working Group?
It is a bilateral forum under the India-U.S. Drug Policy Framework that meets to review and strengthen cooperation against illicit drug trafficking through intelligence sharing, law enforcement, and precursor control.
2. When and where was the 2nd India-U.S. Drug Policy Executive Working Group Meeting held?
The meeting was held in New Delhi on November 2-3, 2026, hosted by the Narcotics Control Bureau (NCB).
3. Who led the Indian and U.S. delegations at the meeting?
The Indian delegation was led by NCB Director General Anurag. The U.S. delegation was led by Debbie Seguin, Acting Deputy Director of the Office of National Drug Control Policy (ONDCP).
4. What is India's Vision Roadmap 2026-2029 mentioned in the meeting?
It is India's anti-drug trafficking strategy formulated under Prime Minister Narendra Modi and Union Home Minister Amit Shah, highlighted at the meeting by the NCB Director General.
All sources
- Original10 November 2026 · Read story
